A case of type C chronic hepatitis with constitutional hyperbilirubinemia treated by peginterferon-alpha + ribavirin + simeprevir

Yoshinori Horie, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Takanori Kanai

Research output: Contribution to journalArticle

Abstract

We reported a case of a 42-y/o man with constitutional hyperbilirubinemia and type C chronic hepatitis treated by peginterferon-alpha + ribavirin + simeprevir. His serum TB level was increased (from 2.5 to 8.1 mg/ dL 3 w after treatment), but gradually decreased thereafter (5.1 mg/dL 4 w after treatment), and recovered (3.0 mg/dL) 4 w after stopping simeprevir. HCV-RNA has been negative and liver function has been normal after treatment. He did not have either any symptom or abnormality in laboratory data except TB level during the treatment. Simeprevir was reported to sometimes increase serum TB level. In this case, organic anion- transporting polypeptide 1B1 (OATP1B1) seems to be inhibited by simeprevir, because the increase in indirect bilirubin was dominant. This case suggests that the treatment for type C chronic hepatitis with simeprevir is possible even in patients with constitutional hyperbilirubinemia, because the increase in serum TB level was temporal and recovered after stopping simeprevir.

Original languageEnglish
Pages (from-to)13-17
Number of pages5
JournalActa Hepatologica Japonica
Volume56
Issue number1
DOIs
Publication statusPublished - 2015

Fingerprint

Hyperbilirubinemia
Ribavirin
Chronic Hepatitis C
Serum
Therapeutics
Bilirubin
Anions
Simeprevir
RNA
Peptides
Liver

Keywords

  • Constitutional hyperbilirubinemia
  • Hepatitis C virus
  • Simeprevir
  • Transporter organic anion-transporting polypeptide 1B1 (OATP1B1)

ASJC Scopus subject areas

  • Hepatology

Cite this

A case of type C chronic hepatitis with constitutional hyperbilirubinemia treated by peginterferon-alpha + ribavirin + simeprevir. / Horie, Yoshinori; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Kanai, Takanori.

In: Acta Hepatologica Japonica, Vol. 56, No. 1, 2015, p. 13-17.

Research output: Contribution to journalArticle

@article{e522a9d8d7ca41fbbc35665df4923b15,
title = "A case of type C chronic hepatitis with constitutional hyperbilirubinemia treated by peginterferon-alpha + ribavirin + simeprevir",
abstract = "We reported a case of a 42-y/o man with constitutional hyperbilirubinemia and type C chronic hepatitis treated by peginterferon-alpha + ribavirin + simeprevir. His serum TB level was increased (from 2.5 to 8.1 mg/ dL 3 w after treatment), but gradually decreased thereafter (5.1 mg/dL 4 w after treatment), and recovered (3.0 mg/dL) 4 w after stopping simeprevir. HCV-RNA has been negative and liver function has been normal after treatment. He did not have either any symptom or abnormality in laboratory data except TB level during the treatment. Simeprevir was reported to sometimes increase serum TB level. In this case, organic anion- transporting polypeptide 1B1 (OATP1B1) seems to be inhibited by simeprevir, because the increase in indirect bilirubin was dominant. This case suggests that the treatment for type C chronic hepatitis with simeprevir is possible even in patients with constitutional hyperbilirubinemia, because the increase in serum TB level was temporal and recovered after stopping simeprevir.",
keywords = "Constitutional hyperbilirubinemia, Hepatitis C virus, Simeprevir, Transporter organic anion-transporting polypeptide 1B1 (OATP1B1)",
author = "Yoshinori Horie and Hirotoshi Ebinuma and Nobuhiro Nakamoto and Takanori Kanai",
year = "2015",
doi = "10.2957/kanzo.56.13",
language = "English",
volume = "56",
pages = "13--17",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "1",

}

TY - JOUR

T1 - A case of type C chronic hepatitis with constitutional hyperbilirubinemia treated by peginterferon-alpha + ribavirin + simeprevir

AU - Horie, Yoshinori

AU - Ebinuma, Hirotoshi

AU - Nakamoto, Nobuhiro

AU - Kanai, Takanori

PY - 2015

Y1 - 2015

N2 - We reported a case of a 42-y/o man with constitutional hyperbilirubinemia and type C chronic hepatitis treated by peginterferon-alpha + ribavirin + simeprevir. His serum TB level was increased (from 2.5 to 8.1 mg/ dL 3 w after treatment), but gradually decreased thereafter (5.1 mg/dL 4 w after treatment), and recovered (3.0 mg/dL) 4 w after stopping simeprevir. HCV-RNA has been negative and liver function has been normal after treatment. He did not have either any symptom or abnormality in laboratory data except TB level during the treatment. Simeprevir was reported to sometimes increase serum TB level. In this case, organic anion- transporting polypeptide 1B1 (OATP1B1) seems to be inhibited by simeprevir, because the increase in indirect bilirubin was dominant. This case suggests that the treatment for type C chronic hepatitis with simeprevir is possible even in patients with constitutional hyperbilirubinemia, because the increase in serum TB level was temporal and recovered after stopping simeprevir.

AB - We reported a case of a 42-y/o man with constitutional hyperbilirubinemia and type C chronic hepatitis treated by peginterferon-alpha + ribavirin + simeprevir. His serum TB level was increased (from 2.5 to 8.1 mg/ dL 3 w after treatment), but gradually decreased thereafter (5.1 mg/dL 4 w after treatment), and recovered (3.0 mg/dL) 4 w after stopping simeprevir. HCV-RNA has been negative and liver function has been normal after treatment. He did not have either any symptom or abnormality in laboratory data except TB level during the treatment. Simeprevir was reported to sometimes increase serum TB level. In this case, organic anion- transporting polypeptide 1B1 (OATP1B1) seems to be inhibited by simeprevir, because the increase in indirect bilirubin was dominant. This case suggests that the treatment for type C chronic hepatitis with simeprevir is possible even in patients with constitutional hyperbilirubinemia, because the increase in serum TB level was temporal and recovered after stopping simeprevir.

KW - Constitutional hyperbilirubinemia

KW - Hepatitis C virus

KW - Simeprevir

KW - Transporter organic anion-transporting polypeptide 1B1 (OATP1B1)

UR - http://www.scopus.com/inward/record.url?scp=84921972186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921972186&partnerID=8YFLogxK

U2 - 10.2957/kanzo.56.13

DO - 10.2957/kanzo.56.13

M3 - Article

AN - SCOPUS:84921972186

VL - 56

SP - 13

EP - 17

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 1

ER -